BibTex RIS Cite

RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION

Year 2010, Volume: 7 Issue: 3, 269 - 276, 01.09.2010

Abstract

References

  • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999;20:247-78.
  • Cardot E, Tillie-Leblond I, Jeannin P, et al: Anaphylactic reaction to local administration of rifamycin SV. J Allergy Clin Immunol 1995;95:1–7.
  • Cooper NJ, Sutton AJ, Abrams KR. Decision analytical eco- nomic modelling within a Bayesian framework: applica- tion to prophylactic antibiotics use for caesarean section. Stat Methods Med Res 2002;11:491–512.
  • Yalcin AN, Bakir M, Bakici Z, Dokmetas I, Sabir N. Postoperative wound infections. J Hosp Infect 1995;29:305-9.
  • Couto RC, Pedrosa TM, Nogueira JM, Gomes DL, Neto MF, Rezende NA. Post-discharge surveillance and infec- tion rates in obstetric patients. Int J Gynaecol Obstet 1998;61:227-31.
  • Noy D, Creedy D. Postdischarge surveillance of surgical site infections: a multi-method approach to data collec- tion. Am J Infect Control 2002;30:417-24.
  • Chaim W, Bashiri A, Bar-David J, Shoham-Vardi I, Mazor M. Prevalence and clinical significance of postpartum endo- metritis and wound infection. Infect Dis Obstet Gynecol 2000;8:77–82.
  • Killian CA, Graffunder EM, Vinciguerra TJ, Venezia RA. Risk factors for surgical-site infections following cesare- an section. Infect Control Hosp Epidemiol 2001;22:613–7.
  • Mitt P, Lang K, Peri A, Maimets M. Surgical-site infections following cesarean section in an Estonian university hos- pital: postdischarge surveillance and analysis of risk fac- tors. Infect Control Hosp Epidemiol 2005;26:449–54.
  • Myles TD, Gooch J, Santolaya J. Obesity as an indepen- dent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol 2002;100 (5 Pt 1):959–64.
  • Schneid-Kofman N, Sheiner E, Levy A, Holcberg G. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet 2005;90:10–5.
  • Yokoe DS, Noskin GA, Cunningham SM, et al. Enhanced identification of postoperative infections. Emerg Infect Dis 2004;10:1924–30.
  • National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992 to June 2002. Am J Infect Control 2002;30:458-75.
  • National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–85.
  • Altemeier WA, Culbertson WR, Hummel RP. Surgical con- siderations of endogenous infections- sources, types, and methods of control. Surg Clin North Am 1968;48:227-40.
  • Wiley AM, Ha’eri GB. Routes of infection: a study of using “tracer particles” in the orthopedic operating room. Clin Orthop 1979;139:150-5.
  • Mastro TD, Farley TA, Elliott JA, et al. An outbreak of surgical-wound infections due to group A streptococcus carried on the scalp. N Engl J Med 1990;323:968-72.
  • Letts RM, Doermer E. Conversation in the operating the- ater as a cause of airborne bacterial contamination. J Bone Joint Surg [Am] 1983;65:357-62.
  • Velasco E, Thuler LC, Martins CA, Dias LM, Conalves VM. Risk factors for infectious complications after abdominal surgery for malignant disease. Am J Infect Control 1996; 24 (1):1-6.
  • Lee JT. Surgical wound infections: surveillance for qual- ity improvement. In: Fry DE, editors. Surgical Infections. Boston, Little, Brown and Co;1995. p. 145-159.
  • Killian CA, Graffunder EM, Vinciguerra TJ, Venezia RA. Risk factors for surgical-site infections following cesare- an section. Infect Control Hosp Epidemiol 2001;22:613–7.
  • Johnson A, Young D, Reilly J. Caesarean section surgical site infection surveillance. J Hosp Infect 2006;64:30–5.
  • Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ. Risk Factors for Surgical Site Infection After Low Transverse Cesarean Section. Infect Control Hosp Epidemiol 2008;29:477–84.
  • Opqien HK, Valbq A, Andersen AG, Walberg M. Post- cesarean surgical site infections according to CDC stan- dards: rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand 2007, 86(9):1097-102.
  • Hardin WD, Nichols RL. Handwashing and patient skin preparation. In: Malangoni MA, editors. Critical Issues in Operating Room Management. Philadelphia, Lippincott- Raven; 1997. p.133-149.
  • Hardin WD, Nichols RL: Aseptic technique in the operat- ing room. In: Fry DE, editors. Surgical Infections. Boston: Little, Brown and Co; 1995. p.109-118.
  • Aly R, Maibach HI. Comparative antibacterial efficacy of a 2-minute surgical scrub with chlorhexidine gluconate, povidone-iodine, and chloroxylenol sponge-brushes. Am J Infect Control 1988;16:173-7.
  • Association of Operating Room Nurses. Recommended practices for skin preparation of patients. AORN J 1996;64(5):813-6.
  • Manncke K, Heeg P. Experimental and clinical studies of the efficacy of an antimicrobial incision drape. Chirurg. 1984;55(8):515-8.
  • Shirahatti RG, Joshi RM, Vishwanath YK, et al. Effect of pre-operative skin preparation on post-operative wound infection. J Postgrad Med 1993;39(3):134-6.
  • Garibaldi RA, Skolnick D, Lerer T, et al. The impact of preoperative skin disinfection on preventing intraopera- tive wound contamination. Infect Control Hosp Epidemiol 1988;9(3):109-13.
  • Lorenz RP, Botti JJ, Appelbaum PC, Bennett N. Skin prep- aration methods before cesarean section. A comparative study. J Reprod Med 1988;33(2):202-4
  • Magann EF, Dodson MK, Ray MA, Harris RL, Martin JN Jr, Morrison JC. Preoperative skin preparation and in- traoperative pelvic irrigation: impact on post-cesare- an endometritis and wound infection. Obstet Gynecol 1993;81(6):922-5
  • Brown TR, Ehrlich CE, Stehman FB, Golichowski AM, Madura JA, Eitzen HE. A clinical evaluation of chlorhexi- dine gluconate spray as compared with iodophor scrub for preoperative skin preparation. Surg Gynecol Obstet. 1984;158(4):363-6.
  • Local application of rifamycin SV in caverns treated by endocavitary aspiration. Arch Tisiol Mal Appar Respir 1963;18:251-6.
  • Benfer J, Struck H.The effect of rifamycin SV on the wound-healing process. Arzneimittelforschung. 1976;26(7):1361-4.
  • Iselin F, Audren JL, Gouet O, Hautefort E, Peze W, Pradet G. Comparative study of the effects of a local antibiotic and a local antiseptic in emergency hand surgery. Ann Chir Main Memb Super 1990;9(1):65-71.
  • Laxenaire MC, Mouton C, Frederic A, Viry-Babel F, Bouchon Y: Anaphylactic shock after tourniquet removal in or- tophedic surgery. Ann Fr Anesth Reanim 1996;15:179–84.
  • Cruse PJ, Foord R: The epidemiology of wound infection: a 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60(1): 27-40.
  • Martone WJ, Jarvis WR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infec- tions. In: Bennett JV, Brachman PS, editors. Hospital Infections. 3rd ed. Boston, Little, Brown and Co; 1992. p. 577-96.
  • Boyce JM, Potter-Bynoe G, Dziobek L. Hospital reimburse- ment patterns among patients with surgical wound infec- tions following open heart surgery. Infect Control Hosp Epidemiol 1990;11(2):89-93.
  • Poulsen KB, Bremmelgaard A, Sorensen AI, Raahave D, Petersen JV: Estimated costs of postoperative wound in- fections. A case-control study of marginal hospital and so- cial security costs. Epidemiol Infect 1994;113(2):283-95.
  • Vegas AA, Jodra VM, Garcia ML. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993;9(5):504-10.
  • Albers BA, Patka P, Haarman HJ, Kostense PJ. Cost ef- fectiveness of preventive antibiotic administration for lowering risk of infection by 0.25%. Unfallchirurg 1994;97(12):625-8.

RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION

Year 2010, Volume: 7 Issue: 3, 269 - 276, 01.09.2010

Abstract

-

References

  • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol 1999;20:247-78.
  • Cardot E, Tillie-Leblond I, Jeannin P, et al: Anaphylactic reaction to local administration of rifamycin SV. J Allergy Clin Immunol 1995;95:1–7.
  • Cooper NJ, Sutton AJ, Abrams KR. Decision analytical eco- nomic modelling within a Bayesian framework: applica- tion to prophylactic antibiotics use for caesarean section. Stat Methods Med Res 2002;11:491–512.
  • Yalcin AN, Bakir M, Bakici Z, Dokmetas I, Sabir N. Postoperative wound infections. J Hosp Infect 1995;29:305-9.
  • Couto RC, Pedrosa TM, Nogueira JM, Gomes DL, Neto MF, Rezende NA. Post-discharge surveillance and infec- tion rates in obstetric patients. Int J Gynaecol Obstet 1998;61:227-31.
  • Noy D, Creedy D. Postdischarge surveillance of surgical site infections: a multi-method approach to data collec- tion. Am J Infect Control 2002;30:417-24.
  • Chaim W, Bashiri A, Bar-David J, Shoham-Vardi I, Mazor M. Prevalence and clinical significance of postpartum endo- metritis and wound infection. Infect Dis Obstet Gynecol 2000;8:77–82.
  • Killian CA, Graffunder EM, Vinciguerra TJ, Venezia RA. Risk factors for surgical-site infections following cesare- an section. Infect Control Hosp Epidemiol 2001;22:613–7.
  • Mitt P, Lang K, Peri A, Maimets M. Surgical-site infections following cesarean section in an Estonian university hos- pital: postdischarge surveillance and analysis of risk fac- tors. Infect Control Hosp Epidemiol 2005;26:449–54.
  • Myles TD, Gooch J, Santolaya J. Obesity as an indepen- dent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol 2002;100 (5 Pt 1):959–64.
  • Schneid-Kofman N, Sheiner E, Levy A, Holcberg G. Risk factors for wound infection following cesarean deliveries. Int J Gynaecol Obstet 2005;90:10–5.
  • Yokoe DS, Noskin GA, Cunningham SM, et al. Enhanced identification of postoperative infections. Emerg Infect Dis 2004;10:1924–30.
  • National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992 to June 2002. Am J Infect Control 2002;30:458-75.
  • National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–85.
  • Altemeier WA, Culbertson WR, Hummel RP. Surgical con- siderations of endogenous infections- sources, types, and methods of control. Surg Clin North Am 1968;48:227-40.
  • Wiley AM, Ha’eri GB. Routes of infection: a study of using “tracer particles” in the orthopedic operating room. Clin Orthop 1979;139:150-5.
  • Mastro TD, Farley TA, Elliott JA, et al. An outbreak of surgical-wound infections due to group A streptococcus carried on the scalp. N Engl J Med 1990;323:968-72.
  • Letts RM, Doermer E. Conversation in the operating the- ater as a cause of airborne bacterial contamination. J Bone Joint Surg [Am] 1983;65:357-62.
  • Velasco E, Thuler LC, Martins CA, Dias LM, Conalves VM. Risk factors for infectious complications after abdominal surgery for malignant disease. Am J Infect Control 1996; 24 (1):1-6.
  • Lee JT. Surgical wound infections: surveillance for qual- ity improvement. In: Fry DE, editors. Surgical Infections. Boston, Little, Brown and Co;1995. p. 145-159.
  • Killian CA, Graffunder EM, Vinciguerra TJ, Venezia RA. Risk factors for surgical-site infections following cesare- an section. Infect Control Hosp Epidemiol 2001;22:613–7.
  • Johnson A, Young D, Reilly J. Caesarean section surgical site infection surveillance. J Hosp Infect 2006;64:30–5.
  • Olsen MA, Butler AM, Willers DM, Devkota P, Gross GA, Fraser VJ. Risk Factors for Surgical Site Infection After Low Transverse Cesarean Section. Infect Control Hosp Epidemiol 2008;29:477–84.
  • Opqien HK, Valbq A, Andersen AG, Walberg M. Post- cesarean surgical site infections according to CDC stan- dards: rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand 2007, 86(9):1097-102.
  • Hardin WD, Nichols RL. Handwashing and patient skin preparation. In: Malangoni MA, editors. Critical Issues in Operating Room Management. Philadelphia, Lippincott- Raven; 1997. p.133-149.
  • Hardin WD, Nichols RL: Aseptic technique in the operat- ing room. In: Fry DE, editors. Surgical Infections. Boston: Little, Brown and Co; 1995. p.109-118.
  • Aly R, Maibach HI. Comparative antibacterial efficacy of a 2-minute surgical scrub with chlorhexidine gluconate, povidone-iodine, and chloroxylenol sponge-brushes. Am J Infect Control 1988;16:173-7.
  • Association of Operating Room Nurses. Recommended practices for skin preparation of patients. AORN J 1996;64(5):813-6.
  • Manncke K, Heeg P. Experimental and clinical studies of the efficacy of an antimicrobial incision drape. Chirurg. 1984;55(8):515-8.
  • Shirahatti RG, Joshi RM, Vishwanath YK, et al. Effect of pre-operative skin preparation on post-operative wound infection. J Postgrad Med 1993;39(3):134-6.
  • Garibaldi RA, Skolnick D, Lerer T, et al. The impact of preoperative skin disinfection on preventing intraopera- tive wound contamination. Infect Control Hosp Epidemiol 1988;9(3):109-13.
  • Lorenz RP, Botti JJ, Appelbaum PC, Bennett N. Skin prep- aration methods before cesarean section. A comparative study. J Reprod Med 1988;33(2):202-4
  • Magann EF, Dodson MK, Ray MA, Harris RL, Martin JN Jr, Morrison JC. Preoperative skin preparation and in- traoperative pelvic irrigation: impact on post-cesare- an endometritis and wound infection. Obstet Gynecol 1993;81(6):922-5
  • Brown TR, Ehrlich CE, Stehman FB, Golichowski AM, Madura JA, Eitzen HE. A clinical evaluation of chlorhexi- dine gluconate spray as compared with iodophor scrub for preoperative skin preparation. Surg Gynecol Obstet. 1984;158(4):363-6.
  • Local application of rifamycin SV in caverns treated by endocavitary aspiration. Arch Tisiol Mal Appar Respir 1963;18:251-6.
  • Benfer J, Struck H.The effect of rifamycin SV on the wound-healing process. Arzneimittelforschung. 1976;26(7):1361-4.
  • Iselin F, Audren JL, Gouet O, Hautefort E, Peze W, Pradet G. Comparative study of the effects of a local antibiotic and a local antiseptic in emergency hand surgery. Ann Chir Main Memb Super 1990;9(1):65-71.
  • Laxenaire MC, Mouton C, Frederic A, Viry-Babel F, Bouchon Y: Anaphylactic shock after tourniquet removal in or- tophedic surgery. Ann Fr Anesth Reanim 1996;15:179–84.
  • Cruse PJ, Foord R: The epidemiology of wound infection: a 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980;60(1): 27-40.
  • Martone WJ, Jarvis WR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infec- tions. In: Bennett JV, Brachman PS, editors. Hospital Infections. 3rd ed. Boston, Little, Brown and Co; 1992. p. 577-96.
  • Boyce JM, Potter-Bynoe G, Dziobek L. Hospital reimburse- ment patterns among patients with surgical wound infec- tions following open heart surgery. Infect Control Hosp Epidemiol 1990;11(2):89-93.
  • Poulsen KB, Bremmelgaard A, Sorensen AI, Raahave D, Petersen JV: Estimated costs of postoperative wound in- fections. A case-control study of marginal hospital and so- cial security costs. Epidemiol Infect 1994;113(2):283-95.
  • Vegas AA, Jodra VM, Garcia ML. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol 1993;9(5):504-10.
  • Albers BA, Patka P, Haarman HJ, Kostense PJ. Cost ef- fectiveness of preventive antibiotic administration for lowering risk of infection by 0.25%. Unfallchirurg 1994;97(12):625-8.
There are 44 citations in total.

Details

Primary Language English
Journal Section Original Articles
Authors

Aydın Köşüş This is me

Nermin Köşüş This is me

Ayşe Güler This is me

Metin Çapar This is me

Publication Date September 1, 2010
Published in Issue Year 2010 Volume: 7 Issue: 3

Cite

APA Köşüş, A., Köşüş, N., Güler, A., Çapar, M. (2010). RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION. European Journal of General Medicine, 7(3), 269-276.
AMA Köşüş A, Köşüş N, Güler A, Çapar M. RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION. European Journal of General Medicine. September 2010;7(3):269-276.
Chicago Köşüş, Aydın, Nermin Köşüş, Ayşe Güler, and Metin Çapar. “RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION”. European Journal of General Medicine 7, no. 3 (September 2010): 269-76.
EndNote Köşüş A, Köşüş N, Güler A, Çapar M (September 1, 2010) RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION. European Journal of General Medicine 7 3 269–276.
IEEE A. Köşüş, N. Köşüş, A. Güler, and M. Çapar, “RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION”, European Journal of General Medicine, vol. 7, no. 3, pp. 269–276, 2010.
ISNAD Köşüş, Aydın et al. “RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION”. European Journal of General Medicine 7/3 (September 2010), 269-276.
JAMA Köşüş A, Köşüş N, Güler A, Çapar M. RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION. European Journal of General Medicine. 2010;7:269–276.
MLA Köşüş, Aydın et al. “RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION”. European Journal of General Medicine, vol. 7, no. 3, 2010, pp. 269-76.
Vancouver Köşüş A, Köşüş N, Güler A, Çapar M. RIFAMYCIN SV APPLICATION TO SUBCUTANEOUS TISSUE FOR PREVENTION OF POST-CESAREAN SURGICAL SITE INFECTION. European Journal of General Medicine. 2010;7(3):269-76.